Guillaume Favier PhD

Partner, Healthcare & Life Sciences Strategy and Performance Transformation

KPMG in the UK

Guillaume focuses on commercial and medical strategy, supporting clients throughout the life cycle of their products from pre-launch to launch execution and life cycle management.

He is a research scientist by background and has worked both in academia and in the industry before becoming a consultant. Outside of work, he is a trustee of two charities: patient association Cardiomyopathy UK and the London Gay Symphonic Winds, an amateur LGBTQ+ wind band.

  • PhD in Organic Chemistry (total synthesis of Herbimycin A, a naturally occurring benzoquinone ansamycin antibiotic)

  • MSc in General Chemistry

  • Commercial Strategy

  • Medical Affairs Strategy

  • Portfolio Strategy

  • Market Development Strategy

  • Opportunity Assessment inc. Disease and Therapeutic Area Assessment